drugset / Trial / NCT00278252

Etoposide in Treating Young Patients With Relapsed Ependymoma

NCT00278252 ↗

Phase 2 Unknown 14 enrolled Children's Cancer and Leukaemia Group
Open-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy, such as etoposide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase II trial is studying how well etoposide works in treating young patients with ependymoma.

Timeline

Start
2001-07
Primary completion
2010-07
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Etoposide Small molecule 100 mg/m2 Intravenous